Ads
    Related paper
  1. CORRECTION OF CARBOHYD-RATE DISORDERS IN PATIENTS WITH PARANOID SCHIZO-PHRENIA, RECEIVING LONG-THERM THERAPY WITH NEUROLYPTICS BY METFORMIN GYDROCHLORIDE
  2. The role of metformin hydrochloride in complex therapy of disorders of carbohydrate metabolism in patients with paranoid schizophrenia treated with atypical antipsychotics
  3. Experimental substantiation of the expediency of the combined use of piracetam and metformin for pharmacological correction of cognitive disorders in conditions of prolonged hyperglycemia
  4. Dynamics of Psychopathological Disorders in Patients with Paranoid Schizophrenia during Atypical Antipsychotic Drugs Therapy
  5. Clinical and psychopathological characteristics and social functioning of patients with hallucinatory-paranoid disorders in moderate vascular dementia
  6. Possibilities of use of metformin for correction of endothelial dysfunction and adaptation reserves of an organism in patients with metabolic syndrome
  7. “VITAMIN B12 DEFICIENCY IN TYPE 2 DIABETES PATIENTS ON LONG TERM METFORMIN THERAPY FOR > 2YEARS”
  8. Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes
  9. INFLUENCE OF NEBIVOLOL ON A HEART RATE VARIABILITY AT THE PATIENTS RECEIVING ANTHRACYCLINE ANTIBIOTICS
  10. INFLUENCE OF TRIMETAZIDINE ON SILENT MYOCARDIAL ISCHEMIA AND HEART RATE VARIABILITY AT THE PATIENTS RECEIVING ANTHRACYCLINE ANTIBIOTICS